These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9879347)
1. [The photon therapy of subfoveal choroidal neovascularization in age-dependent macular degeneration. The results of a prospective study in 40 patients]. Prettenhofer U; Haas A; Mayer R; Oechs A; Pakisch B; Stranzl H; Willfurth P; Hackl A Strahlenther Onkol; 1998 Dec; 174(12):613-7. PubMed ID: 9879347 [TBL] [Abstract][Full Text] [Related]
2. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Hart PM; Chakravarthy U; Mackenzie G; Chisholm IH; Bird AC; Stevenson MR; Owens SL; Hall V; Houston RF; McCulloch DW; Plowman N Arch Ophthalmol; 2002 Aug; 120(8):1029-38. PubMed ID: 12149056 [TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Bergink GJ; Deutman AF; van den Broek JF; van Daal WA; van der Maazen RW Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):591-8. PubMed ID: 7528158 [TBL] [Abstract][Full Text] [Related]
4. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Kobayashi H; Kobayashi K Am J Ophthalmol; 2000 Nov; 130(5):617-35. PubMed ID: 11078841 [TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration. Ophthalmology; 1999 Dec; 106(12):2239-47. PubMed ID: 10599652 [TBL] [Abstract][Full Text] [Related]
6. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Valmaggia C; Ries G; Ballinari P Am J Ophthalmol; 2002 Apr; 133(4):521-9. PubMed ID: 11931786 [TBL] [Abstract][Full Text] [Related]
8. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Marcus DM; Sheils W; Johnson MH; McIntosh SB; Leibach DB; Maguire A; Alexander J; Samy CN Arch Ophthalmol; 2001 Feb; 119(2):171-80. PubMed ID: 11176977 [TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [TBL] [Abstract][Full Text] [Related]
10. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization. Jaakkola A; Heikkonen J; Tarkkanen A; Immonen I Acta Ophthalmol Scand; 1999 Feb; 77(1):57-61. PubMed ID: 10071150 [TBL] [Abstract][Full Text] [Related]
11. A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration. Valmaggia C; Ries G; Ballinari P Doc Ophthalmol; 2001 Nov; 103(3):201-9. PubMed ID: 11824657 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study. Donati G; Soubrane D; Quaranta M; Coscas G; Soubrane G Br J Ophthalmol; 1999 Jun; 83(6):646-51. PubMed ID: 10340969 [TBL] [Abstract][Full Text] [Related]
13. Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy. Hoeller U; Fuisting B; Schwartz R; Roeper B; Richard G; Alberti W Eye (Lond); 2005 Nov; 19(11):1151-6. PubMed ID: 15543182 [TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy for choroidal neovascularization in age-related macular degeneration. A pilot study using low- versus high-dose photon bean radiation]. Thölen AM; Meister A; Bernasconi PP; Messmer EP Ophthalmologe; 1998 Oct; 95(10):691-8. PubMed ID: 9828635 [TBL] [Abstract][Full Text] [Related]
15. [3 years experience with low dosage fractionated percutaneous teletherapy in subfoveal neovascularization. Clinical results]. Schittkowski M; Schneider H; Grüschow K; Ziegler PG; Guthoff R; Fietkau R Strahlenther Onkol; 2001 Jul; 177(7):345-53. PubMed ID: 11505620 [TBL] [Abstract][Full Text] [Related]
16. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA; Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056 [TBL] [Abstract][Full Text] [Related]
17. Long-term results after external radiotherapy in age-related macular degeneration. A prospective study. Prettenhofer U; Haas A; Mayer R; Stranzl H; Oechs A; Hackl A Strahlenther Onkol; 2004 Feb; 180(2):91-5. PubMed ID: 14762661 [TBL] [Abstract][Full Text] [Related]
18. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963 [TBL] [Abstract][Full Text] [Related]